Bendamustine in combination with ifosfamide, etoposide, and vinorelbine (VIBE) is an effective salvage regimen for heavily pre-treated patients with relapsed or refractory Hodgkin lymphoma: a single-center experience

BACKGROUND: This study evaluated the outcomes of patients with refractory/relapsed Hodgkin lymphoma (RRHL) treated with a bendamustine-based regimen in combination with ifosfamide, etoposide, and vinorelbine (VIBE). METHODS: Consecutive RRHL patients who were treated with the VIBE regimen were ident...

Descripción completa

Detalles Bibliográficos
Autores principales: Prakash, Gaurav, Jain, Arihant, Sahu, Kamalkant, Bal, Amanjit, Singh, Charanpreet, Basher, Rajender, Singh, Harmandeep, Mishra, Kundan, Jandial, Aditya, Lad, Deepesh, Khadwal, Alka, Srinivasan, Radhika, Das, Ashim, Varma, Neelam, Varma, Subhash, Malhotra, Pankaj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478624/
https://www.ncbi.nlm.nih.gov/pubmed/34400589
http://dx.doi.org/10.5045/br.2021.2021039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478624/
https://www.ncbi.nlm.nih.gov/pubmed/34400589
http://dx.doi.org/10.5045/br.2021.2021039

Ejemplares similares